Jacobs Levy Equity Management’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
VCM
ACH
WA
PCH
Jacobs Levy Equity Management's AXGN Position: Q1 2026 in Review
Jacobs Levy Equity Management reduced its Axogen (AXGN) stake by 1.2% in Q1 2026, selling an estimated $152K and leaving 384,654 shares worth $12.7M. The position accounts for 0.05% of the portfolio, ranked #277.
Jacobs Levy Equity Management first reported a position in AXGN in Q4 2019 and has held it in 24 quarters since. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.
- Jacobs Levy Equity Management held 384,654 shares of Axogen worth $12.7M as of Q1 2026.
- Jacobs Levy Equity Management sold 4,689 Axogen shares in Q1 2026, an estimated $152K.
- Axogen made up 0.05% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #277 holding.
- Jacobs Levy Equity Management first reported a position in Axogen in Q4 2019 and has held it in 24 quarters since.
- 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.